FDA User Fee Bill: House Cmte. Makes Technical Changes, Adds Pricing Resolution

House Energy and Commerce Committee refines FDA Reauthorization Act and adopts a ‘sense of Congress’ resolution on drug pricing, but largely steers clear of other potentially controversial add-ons that could bog down the measure.